期刊文献+

泻心汤中药效成分的吸收机制与相互作用 被引量:2

Investigation of the absorption mechanism and interactions among active components in Xiexin decoction
原文传递
导出
摘要 目的研究泻心汤药中效成分黄芩苷、大黄酸、盐酸小檗碱在Caco-2细胞单层模型的吸收机制和相互作用。方法采用Caco-2细胞单层模型研究黄芩苷、大黄酸、盐酸小檗碱由绒毛面(AP侧)到基底面(BL侧)的转运过程,采用HPLC法测定药物在BL侧的累积量,通过计算表观渗透系数(Papp),比较配伍前后药物Papp的差别,探讨药物的跨细胞转运机制和相互作用。结果泻心汤药效成分黄芩苷、大黄酸、盐酸小檗碱在考察的浓度范围内皆以被动扩散为主要跨细胞转运方式,配伍前后药物的Papp无统计学差异。结论泻心汤中药效成分跨细胞转运方式为被动扩散,在转运过程中,药物之间无影响。 OBJECTIVE To investigate the absorption mechanism and interactions among active components in Xiexin decoction(baicalin,rhein and berberine hydrochloride) by Caco-2 cell monolayer model.METHODS The transport process of baicalin,rhein and berberine hydrochloride from apical side(AP) to basolateral side(BL)was studied,the cumulative amount in the basolateral side was measured by HPLC,then the apparent permeability coefficient(Papp)was calculated and the Papp values before and after compatibility was compared to discuss the drug transport mechanism and interaction.RESULTS The absorption and transport of active components in Xiexin decoction(baicalin,rhein and berberine hydrochloride) was passive diffusion as the dominating process in Caco-2 cell monolayer model.There was no significanl different between the Papp values before and after compatibility.CONCLUSION The absorption and transport of active components in Xiexin decoction was passive diffusion as the dominating process,and there was no drug interaction between baicalin,rhein and berberine hydrochloride when they transported from apical side to basolateral side.
出处 《华西药学杂志》 CAS CSCD 北大核心 2011年第4期339-341,共3页 West China Journal of Pharmaceutical Sciences
基金 国家自然科学基金资助项目(批准号:30873441) 教育部博士点基金项目(项目编号:20070610047)
关键词 CACO-2细胞模型 泻心汤 药效成分 吸收机制 相互作用 Caco-2 cells Xiexin decoction Active components Absorption mechanism Interaction
  • 相关文献

参考文献4

二级参考文献11

  • 1ARTURSSON P,PALM K,LUTHMAN K.Caco-2 monolayers in experimental and theoretical predictions of drug transport[J].Adv Drug Deliv Rev,2001,46(1-3):27-43.
  • 2SHA X,FANG X.Transport characteristicx of 9-nitrocamptothexin in the human intestinal cell line Caco-2 and everted gut secs[J].Int J Pharm,2004,272:161-171.
  • 3SHEN J,JIAO Z,LI Z D,et al.HPLC determination of telmisartan in human plasma and its application to a pharmacokinetic study[J].Die Pharmazie,2005,60(5):418-420.
  • 4SCHINKEL A H,JONKER J W.Mammalian drug efflux transporters of the ATP binding cassette(ABC)family:an overview[J].Adv Drug Deliv Rev,2003,55 (1):3-29.
  • 5MARZOLINI C,PAUS E,BUCLIN T,et al.Polymorphisms in human MDR1 (P-glycoprotein):recent advances and clinical relevance[J].Clin Pharmacol 7her,2004,75(1):13-33.
  • 6STANGIER J,SU C A,HENDRIKS M G,et al.The effect of TMS on the steady-state pharmacokinetics of digoxin in healthy male volunteers[J].J Clin Pharmacol,2000,40(12):1373-1379.
  • 7DANTZIG A H,ALWIS D P,BURGESS M.Considerations in the design and development of transport inhibitors as adjuncts to drug therapy[J].Adv Drug Deliv Rev,2003,55(1):133-150.
  • 8SHARPE M,JARVIS B,GOA K L.Telmisartan:a review of its use in hypertension[J].Drugs,2001,61(10):1501-1529.
  • 9乔梁,彭嘉柔,濮训生,魏璐雪.黄连─黄芩药对煎煮液沉淀物的分析[J].中国中药杂志,1999,24(6):352-353. 被引量:42
  • 10刘云海,林爱华,丁水平,方建国,李敬,陈新.板蓝根氯仿提取物及其4组份抗内毒素作用比较[J].中国医院药学杂志,2001,21(6):326-328. 被引量:20

共引文献25

同被引文献59

引证文献2

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部